<div class="slide8" id="slide8">
	<h1><a href="#">One-Tablet, Once-Daily Xarelto<sup>&reg;</sup> -<br/>More Protection with Less Worry<sup>7</sup></a></h1>
	<p><em>Superior protection in one simple fixed dose<sup>7</sup></em></p>
		<dl class="diamonds wide">
		<dt>20 mg</dt>
		<dd><img src="content/images/administration/pill.png" alt=""/><p>One 20-mg tablet, once daily for your AF patients<sup>7</sup></p></dd>
	</dl>

	<p class="ref">One 15-mg tablet, once daily for patients with moderate renal impairment (creatinine clearance of 30-49 mL/min)<sup>7</sup></p>

	<ul class="foldouts clickAndAnimate">
		<li>
			<a href="#" class="toggler">
				<h3>Simple to initiate</h3>
				<div class="content">
					<ul>
						<li>For your new AF patients, Xarelto provides protection from day one<sup>15</sup></li>
						<li>For AF patients taking VKA, stop VKA treatment. Once INR â‰¤ 3.0, start Xarelto<sup>7</sup></li>
					</ul>
				</div>
			</a>
		</li>

		<li>
			<a href="#" class="toggler">
				<h3>Simple to manage</h3>
				<div class="content">
					<ul>
						<li>No coagulation monitoring, low risk of drug-drug interactions, no dietary restrictions<sup>8</sup></li>
						<li>Good tolerability<sup>12</sup></li>
					</ul>
				</div>
			</a>
		</li>
	</ul>

	<div class="ref bottom">
		<p>VKA= vitamin K antagonist.<br/>Xarelto is not recommended for patients with prosthetic heart valves.<br />
		INR values should not be used. They are not a dependable measure of the anticoagulant activity of Xarelto.</p>
	</div>
</div>
